About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Ashland Purchases Manufacturing Rights for VitalET and TPM

June 20, 2019August 28, 2019

Click here to read more

Post navigation

Change of Company Name and ASX Code

Avecho investor update – webinar recording

Related Posts

2016 July 29 CEO Quarterly Update

July 29, 2016

Landmark Agreement with Perrigo

December 20, 2022December 20, 2022

Phosphagenics Reports Positive Resuls for Weaner Pig Efficiency Trial

January 20, 2016

Recent Posts

Euroz Hartleys | Successful Phase 3 Interim Results
July 8, 2026
Avecho Phase III insomnia trial advances following positive interim analysis
June 24, 2026
Euroz Hartleys Initiates Research Coverage
May 21, 2026

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.